Lidak Pharm. [LDAKA] Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA]

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: henry jakala who wrote (667)	10/16/1997 9:55:00 PM
From: mannyj	of 1115

note Company Press Release LIDAK Announces Management Change LA JOLLA, Calif., Oct. 16 /PRNewswire/ -- LIDAK Pharmaceuticals (Nasdaq:LDAKA) reported that Susan Yeagley Sullivan, who joined the Company one month ago, has resigned as chief financial officer. Dr. David H. Katz has re-assumed the CFO duties until a replacement is appointed. LIDAK Pharmaceuticals is developing therapeutic products against virally caused diseases, inflammatory disorders, allergies and asthma, and cancer. SOURCE Lidak Pharmaceuticals More news for referenced ticker symbols: LDAKA, and related industries: healthcare, medical. Help this sure doesn't speak well for lidak

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next